Fairvalue-Calculator Fairvalue-Calculator
EN DE

Impact BioMedical Inc (IBO) Fair Value & Analysis

Healthcare · US · Market cap $54.1M

Price$0.5379
Fair Value$0.5300
Upside-1.5%
Quality80/100
Evidence: Low Range $0.3900 – $0.6600

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Impact BioMedical Inc (IBO) currently trades at $0.5379, while our model-based Fair Value estimate is $0.5300 — implying the stock looks roughly 1.5% overvalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrat…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Impact BioMedical Inc (IBO) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.5300 versus a price of $0.5379 — about −1% (overvalued). Model-based estimate, not financial advice.
What is the fair value of IBO?
Our 21-model fair value for Impact BioMedical Inc is $0.5300 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.5379.
What is the quality score of IBO?
Impact BioMedical Inc has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.